HCMV GB TRAFFICKING IN POLARIZED EPITHELIAL CACO 2 CELLS
HCMV GB TRAFFICKING IN POLARIZED EPITHELIAL CACO 2 CELLS
批准号:
6510192
负责人:
MICHAEL ARTHUR JARVIS
金额:
$5.01万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-03-01 至
中文摘要
骨髓移植是治疗白血病的有效方法。然而,医源性免疫抑制使患者容易受到人类巨细胞病毒(HCMV)感染的影响。在体内,人巨细胞病毒可感染成纤维细胞、神经细胞和上皮细胞。在这些细胞类型中,了解必要的病毒蛋白复合体GB转运到感染性病毒产生部位(S)的机制可能对产生新的抗病毒化合物很重要。该建议的目的是研究GB在上皮细胞系(Caco-2)中的转运机制。
英文摘要
Bone marrow transplantation is an effective treatment for leukemia. However, the iatrogenic immunosuppression leaves the patient susceptible to disease as a result of human cytomegalovirus (HCMV) infection. In vivo, fibroblastic, neuronal and epithelial cells are infected by HCMV. In these cell types, understanding the mechanisms by which the essential viral protein complex gB traffics to the site(s) of infectious virus production may be important for the generation of new anti-viral compounds. The aim of this proposal is to investigate the trafficking of mechanisms of gB in an epithelial line (Caco-2).
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Phosphorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgi network and efficient virus replication.
人巨细胞病毒糖蛋白 B (gB) 在酸性簇酪蛋白激酶 2 位点 (Ser900) 的磷酸化是 gB 定位到跨高尔基体网络和有效病毒复制所必需的。
DOI:
10.1128/jvi.78.1.285-293.2004
发表时间:
2004
期刊:
Journal of virology
影响因子:
5.4
作者:
[Jarvis,MichaelA, Jones,ThomasR, Drummond,DerekD, Smith,PatsyP, Britt,WilliamJ, Nelson,JayA, Baldick,CarlJ]
通讯作者:
Baldick,CarlJ
Development of a founder-based CMV vaccine to interrupt Ebola virus transmission
-
批准号:7874794
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2010
-
负责人:MICHAEL ARTHUR JARVIS
-
依托单位:
Development of a founder-based CMV vaccine to interrupt Ebola virus transmission
-
批准号:8037799
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2010
-
负责人:MICHAEL ARTHUR JARVIS
-
依托单位:
HCMV GB TRAFFICKING IN POLARIZED EPITHELIAL CACO 2 CELLS
-
批准号:6362260
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2001
-
负责人:MICHAEL ARTHUR JARVIS
-
依托单位:
HCMV GB TRAFFICKING IN POLARIZED EPITHELIAL CACO 2 CELLS
-
批准号:6135018
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2000
-
负责人:MICHAEL ARTHUR JARVIS
-
依托单位:
海外基金